Waytron has a long-term and stable relationship with many carriers. With our strong strength, professional team, scientific system and sound network, Waytron can provide our customers with one-stop global logistics services, which are now can be involved in many countries such as USA, Canada, Europe, Australia and southeast Asia, and so on. Waytron can handle FCL, LCL, and special shipments, also providing reliable SOC service and competitive rates for TP trades, especially to USA and Canada inland locations, such as Dallas, El Paso, Portland, Houston, Calgary and Winnipeg.
Waytron Overseas Department is in charge of working with the overseas agents, including D/O, Customs Clearance, Door Delivery and Transshipment to ensure the high-quality services.
-
32% Combined Tariff Rate: Body wash falls under HTS code 3401.19.00 (other surface-active agents) or 3401.30.00 (other preparations for use in cosmetics), subject to a 32% combined duty rate for Chinese-origin products—per 2025 U.S. reciprocal tariff updates (replacing the prior 16% rate). For a
Eliminated De Minimis Exemption: All shipments, including small-batch ocean consolidations under $800, are subject to full tariffs. Low-volume orders (e.g., 600-unit sample consignments for boutique retail chains) now require formal duty planning, eliminating cost advantages for small exporters and necessitating precise pricing strategies to maintain competitiveness in the U.S. market.
Strict Origin Determination: CBP applies a "substantial transformation" test—body wash formulated, mixed, or packaged in China (even with foreign-sourced raw materials like imported hyaluronic acid or surfactant blends) qualify as Chinese-origin. Partial foreign content (e.g., 35% imported natural extracts) does not exempt shipments from the 32% tariff, as ingredient mixing, fragrance blending, and bottle filling processes are deemed minimal processing that does not alter origin classification.
HTS Classification Mandates: Importers must correctly declare the appropriate HTS subheading based on product type and functionality. Misclassification (e.g., labeling antibacterial body wash as "general cosmetics" under HTS 3401.30.00 instead of the correct 3401.19.00 for surface-active agent-based products) triggers penalty duties of up to 180% of unpaid amounts and extended detention periods (average 32+ days), as CBP closely monitors cosmetic classifications to prevent tariff evasion.
FDA Ingredient Restrictions: 2025 FDA regulations (21 CFR Part 73 and 74) impose strict rules on body wash ingredients to protect consumer health:
Prohibited Ingredients: Specific substances are banned in body wash, including mercury compounds (≤1ppm), formaldehyde and formaldehyde releasers (e.g., DMDM hydantoin, imidazolidinyl urea) – aligning with Washington State’s 2025 cosmetic chemical ban, and certain phthalates (e.g., diethyl phthalate, dibutyl phthalate) used in fragrance formulations.
Restricted Antibacterial Agents: For antibacterial body wash, EPA-approved active ingredients (e.g., triclosan, benzalkonium chloride) are subject to strict concentration limits (e.g., triclosan ≤0.3%). Unapproved antibacterial agents (e.g., chlorhexidine gluconate above 0.5%) result in immediate shipment seizure.
Surfactant Standards: Primary surfactants (e.g., sodium lauryl sulfate, cocamidopropyl betaine) must meet purity standards (≥95% purity) to avoid skin irritation. Contaminants like 1,4-dioxane (a byproduct of surfactant manufacturing) must be below detectable limits (≤10ppb).
Microbial Safety Standards: The FDA’s Good Manufacturing Practices (GMP) for cosmetics (21 CFR Part 211) require body wash to meet strict microbial limits:
Total Aerobic Bacteria: ≤1,000 CFU/g (colony-forming units per gram) for all body wash variants.
Yeast & Mold: ≤100 CFU/g across all product types.
Pathogenic Bacteria: No detectable levels of E. coli, Staphylococcus aureus, Pseudomonas aeruginosa, or Candida albicans. Mandatory third-party testing via plate count method or PCR (polymerase chain reaction) is required for each shipment.
pH & Stability Requirements: Body wash must have a pH range of 4.5–8.5 to ensure skin compatibility; deviations outside this range trigger CBP scrutiny. Additionally, stability testing (simulating 6 months of storage at 25°C/60% RH and 40°C/75% RH) is mandatory to confirm no formula separation, color change, or odor degradation—key factors in preventing consumer complaints and regulatory rejection.
Documentation Mandates: Ocean shipments must include a comprehensive set of documents to prove compliance:
FDA-recognized third-party lab reports verifying ingredient compliance, microbial safety, pH levels, and stability testing.
Material Safety Data Sheets (MSDS) for all ingredients (e.g., surfactants, preservatives, fragrances, antibacterial agents) and packaging materials.
A "Declaration of Conformity" signed by the exporter, confirming adherence to FDA regulations (21 CFR Parts 73, 74, and 211) and GMP standards.
For antibacterial body wash: EPA Registration Certificate for the active ingredient, detailing approved uses and concentration limits.
Mandatory Label Elements (per FDA, FTC, and EPA regulations):
Origin & Product Labeling: Each body wash bottle and outer carton must clearly display "Made in China" (font height ≥1.2mm for bottles, ≥1.6mm for cartons) and the exact product type (e.g., "Moisturizing Body Wash," "Antibacterial Exfoliating Body Wash"). Ambiguous labels like "Body Cleanser" without specific type are prohibited.
Ingredient List: A complete INCI (International Nomenclature of Cosmetic Ingredients) list in descending order of weight must be printed on the primary package (e.g., bottle back) or outer carton for multi-unit packs. Fragrance may be labeled as "fragrance," but allergenic components (e.g., linalool, limonene) present above 0.01% must be individually disclosed.
Safety Warnings: Labels must include "For external use only," "Avoid contact with eyes – rinse thoroughly if contact occurs," "Discontinue use if irritation occurs," and "Keep out of reach of children under 3 years" (for small bottles with choking hazard). For antibacterial variants: "Use only as directed" and "Do not use on broken skin."
Batch/Lot Number & Expiry Date: A unique batch/lot number and expiration date (or "best before" date) must be marked on each bottle and carton. The batch number must be traceable to production records (ingredient sources, manufacturing date, testing results).
EPA Mark for Antibacterial Variants: Antibacterial body wash must display the EPA Registration Number and "EPA Approved" mark on the front label, ensuring compliance with environmental and health regulations.
Prohibited Claims:
Misleading "Natural" or "Organic" Claims: Phrases like "100% Natural Body Wash" are only permissible if all ingredients are derived from natural sources (no synthetic preservatives, fragrances, or surfactants) and supported by third-party certification (e.g., USDA Organic for plant-based extracts).
Health or Therapeutic Claims: Statements like "Treats eczema," "Cures fungal infections," or "Prevents bacterial diseases" classify the product as an unapproved drug under the FD&C Act, leading to shipment seizure and FTC fines of up to $8,000 per violation.
Unsubstantiated Efficacy Claims: Phrases like "Clinically Proven to Moisturize for 24 Hours" or "Kills 99.9% of Germs" require supporting data—moisturizing claims need instrumental testing (e.g., corneometer for skin hydration), while antibacterial claims need EPA-approved efficacy studies.
"Hypoallergenic" Claims: Require third-party patch testing on 50+ participants with sensitive skin, with no adverse reactions reported.
Ingredient Sourcing & Product Testing:
Verify Ingredient Legitimacy: Work exclusively with FDA/EPA-approved ingredient suppliers who can provide valid Certificates of Analysis (CoA) for each batch. Prioritize suppliers with GMP certifications (e.g., ISO 22716) to ensure ingredient purity and safety. For antibacterial body wash, source active ingredients only from EPA-registered manufacturers and retain registration documents for 5 years (EPA requirement).
Conduct Mandatory Testing: Submit 10–15 body wash samples per batch to a FDA-recognized third-party lab (e.g., Eurofins, SGS) for:
Ingredient verification via HPLC (high-performance liquid chromatography) or GC-MS (gas chromatography-mass spectrometry) to confirm compliance with FDA limits.
Microbial testing (plate count, pathogen detection) to meet safety standards.
pH testing (using calibrated pH meters) to ensure skin compatibility.
Stability testing: Expose samples to simulated ocean transit conditions (temperature 15–30°C, humidity 60–85%) for 45 days to check for formula separation, color change, or odor degradation.
For antibacterial variants: Additional efficacy testing to confirm compliance with EPA-approved germ-killing claims.
Implement In-House Quality Control: Before packaging, conduct 100% visual inspections of each bottle to identify defects (e.g., leaking caps, damaged labels, incorrect fill levels) and 5% random sampling for weight consistency (±5% of labeled weight). Reject rates exceeding 2% indicate production issues that require corrective action (e.g., adjusting cap sealing pressure) to avoid CBP rejection.
Packaging & Container Loading Best Practices:
Individual Product Protection: Use leak-proof, impact-resistant bottles (e.g., HDPE or PET plastic) with tamper-evident caps (e.g., induction seals or tear-off strips) to prevent leakage during transit. For glass bottles (used for premium variants), wrap each bottle in bubble wrap or foam sleeves to avoid breakage.
Carton Design for Transit Safety: Use double-walled corrugated cartons with a bursting strength of ≥200 psi to withstand stacking pressure. Line cartons with absorbent pads (e.g., cellulose-based pads) to contain leaks in case of bottle breakage—critical for preventing cross-contamination of other products in the container.
Temperature & Humidity Control: For temperature-sensitive body wash (e.g., those containing natural extracts or probiotics), use insulated packaging (e.g., foam coolers) with phase-change materials (PCMs) to maintain a temperature range of 15–25°C. Include silica gel packets (15g per carton) to absorb excess moisture and prevent label smudging or mold growth on outer packaging.
Loading Strategy to Minimize Damage:
Stack cartons on pallets elevated 12cm above container floors to avoid water damage from floor condensation. Use heat-treated wooden pallets (per ISPM 15) or plastic pallets—untreated wood is rejected by CBP due to pest infestation risks.
Limit pallet height to 1.8m to prevent crushing lower cartons—excessive weight can cause bottle deformation or cap failure. Distribute weight evenly, placing heavier cartons (e.g., 1L bottle packs) at the bottom and lighter ones (e.g., 250ml travel-size packs) on top.
Secure pallets with stretch wrap (3 layers minimum) and load-bearing straps to prevent shifting during vessel movement. Use corner protectors on pallet edges to avoid carton tearing and bottle damage.
Labeling Compliance: Ensure outer cartons display all mandatory labels (origin statement, batch number, expiry date, safety warnings, EPA mark for antibacterial variants) and shipping labels with "Fragile," "Handle with Care," "Temperature Controlled (15–25°C)," and "Liquid – Keep Upright" markings. Use water-resistant ink and durable label materials to prevent smudging or peeling during transit.
Documentation Organization:
Compile a comprehensive compliance packet for CBP, including:
Commercial invoice with accurate declared value (no under-invoicing, which triggers CBP audits for cosmetics), correct HTS code, and origin statement ("Chinese-origin per CBP substantial transformation test, ingredients from FDA/EPA-approved suppliers").
Third-party lab reports (ingredient verification, microbial testing, pH testing, stability testing, efficacy testing for antibacterial variants).
MSDS for all ingredients and packaging materials.
Declaration of Conformity signed by a company executive, listing all applicable regulations (FDA 21 CFR Parts 73, 74, 211; EPA regulations for antibacterial products) and confirming compliance.
For antibacterial body wash: EPA Registration Certificate for the active ingredient and efficacy test reports.
Packing list with carton quantities, unit counts per carton, batch/lot number cross-references, and product type (e.g., "Moisturizing Body Wash – 500ml – Batch #BW202509").
Supplier CoA for high-risk ingredients (e.g., preservatives, antibacterial agents, natural extracts).
Transit Monitoring & Coordination:
Use Real-Time Tracking Tools: Partner with a freight forwarder that offers container tracking with temperature and humidity monitoring (via IoT sensors). Set up alerts for deviations from optimal conditions (temperature <10°C or >30°C, humidity >80%) to take proactive action—for example, requesting expedited unloading at the port or arranging climate-controlled storage if temperature fluctuations occur.
Pre-Arrival Documentation Submission: Coordinate with the freight forwarder to file the ACE (Automated Commercial Environment) manifest and submit all compliance documents to CBP at least 72 hours before the vessel reaches the U.S. port. This allows CBP to review documents in advance and reduces clearance time by 35% on average for cosmetic shipments.
Communicate with U.S. Customs Broker: Designate a U.S.-based customs broker experienced in importing body wash to act as a liaison with CBP. The broker can address minor documentation issues (e.g., missing CoA signatures) quickly and provide guidance if CBP requests physical inspections or additional testing.
Delay Planning & Contingency Measures:
Allocate Buffer Time: Account for 10–15 days of buffer time for inspections—75% of Chinese body wash shipments face partial or full CBP screening, including physical inspection of products and verification of lab reports. Avoid time-sensitive orders (e.g., holiday retail stock for Black Friday or summer skincare promotions) that cannot absorb delays, as detained shipments often miss seasonal deadlines.
Prepare for Additional Testing: If CBP requests additional testing (e.g., for prohibited ingredients or microbial contamination), have a pre-arranged contract with a U.S.-based lab to expedite testing. This reduces waiting time from 12 days to 4–6 days and minimizes port storage fees (average $95 per day per container).
Develop a Seizure Response Plan: In case of shipment seizure (e.g., due to unapproved antibacterial agents), work with a U.S. trade attorney specializing in FDA/CBP/EPA regulations to file a petition for release. Provide additional documentation (e.g., supplier audits, batch records, revised testing reports) to prove compliance and avoid permanent forfeiture.